The Transcription Factor PU.1 Controls Dendritic Cell Development and Flt3 Cytokine Receptor Expression in a Dose-Dependent Manner

被引：225

作者：

Carotta, Sebastian ^{[1
]}

Dakic, Aleksandar ^{[1
]}

D'Amico, Angela ^{[1
]}

Pang, Swee Heng Milon ^{[1
,2
]}

Greig, Kylie T. ^{[1
,2
]}

Nutt, Stephen L. ^{[1
]}

Wu, Li ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia

[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia

来源：

IMMUNITY | 2010年 / 32卷 / 05期

基金：

英国医学研究理事会; 澳大利亚研究理事会;

关键词：

LINEAGE-COMMITMENT; TARGETED DISRUPTION; C/EBP-ALPHA; STEM-CELLS; LIGAND; PROGENITORS; MACROPHAGE; IDENTIFICATION; MAINTENANCE; GENERATION;

D O I：

10.1016/j.immuni.2010.05.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The transcription factor PU.1 plays multiple context and concentration dependent roles in lymphoid and myeloid cell development. Here we showed that PU.1 (encoded by Sfpi1) was essential for dendritic cell (DC) development in vivo and that conditional ablation of PU.1 in defined precursors, including the common DC progenitor, blocked Flt3 ligand-induced DC generation in vitro. PU.1 was also required for the parallel granulocyte-macrophage colony stimulating factor-induced DC pathway from early hematopoietic progenitors. Molecular studies demonstrated that PU.1 directly regulated Flt3 in a concentration-dependent manner, as Sfpi1(+/-) cells displayed reduced expression of Flt3 and impaired DC formation. These studies identify PU.1 as a critical regulator of both conventional and plasmacytoid DC development and provide one mechanism how altered PU.1 concentration can have profound functional consequences for hematopoietic cell development.

引用

页码：628 / 641

页数：14

共 51 条

[11] Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, RP
Singh, H
[J]. SCIENCE, 2000, 288 (5470) : 1439 - 1441
[12] PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells
Guerriero, A
Langmuir, PB
Spain, LM
Scott, EW
[J]. BLOOD, 2000, 95 (03) : 879 - 885
[13] Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse
Hayashi, S
McMahon, AP
[J]. DEVELOPMENTAL BIOLOGY, 2002, 244 (02) : 305 - 318
[14] HOHAUS S, 1995, MOL CELL BIOL, V15, P5830
[15] Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment
Holmes, ML
Carotta, S
Corcoran, LM
Nutt, SL
[J]. GENES & DEVELOPMENT, 2006, 20 (08) : 933 - 938
[16] Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality
Houston, Isaac B.
Kamath, Meghana B.
Schweitzer, Brock L.
Chlon, Timothy M.
DeKoter, Rodney P.
[J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (07) : 1056 - 1068
[17] Bifurcation dynamics in lineage-commitment in bipotent progenitor cells
Huang, Sui
Guo, Yan-Ping
May, Gillian
Enver, Tariq
[J]. DEVELOPMENTAL BIOLOGY, 2007, 305 (02) : 695 - 713
[18] GENERATION OF LARGE NUMBERS OF DENDRITIC CELLS FROM MOUSE BONE-MARROW CULTURES SUPPLEMENTED WITH GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
INABA, K
INABA, M
ROMANI, N
AYA, H
DEGUCHI, M
IKEHARA, S
MURAMATSU, S
STEINMAN, RM
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1693 - 1702
[19] Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation
Iwasaki, H
Somoza, C
Shigematsu, H
Duprez, EA
Iwasaki-Arai, J
Mizuno, S
Arinobu, Y
Geary, K
Zhang, P
Dayaram, T
Fenyus, ML
Elf, S
Chan, S
Kastner, P
Huettner, CS
Murray, R
Tenen, DG
Akashi, K
[J]. BLOOD, 2005, 106 (05) : 1590 - 1600
[20] Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo
Karsunky, H
Merad, M
Cozzio, A
Weissman, IL
Manz, MG
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) : 305 - 313

← 1 2 3 4 5 6 →